Emergency Department Management of Recent-Onset Atrial Fibrillation

被引:2
|
作者
Weant, Kyle A. [1 ]
Matuskowitz, Andrew J. [2 ]
Gregory, Haili [1 ]
Caporossi, Jeffrey [2 ]
Hall, Gregory A. [2 ]
机构
[1] Med Univ South Carolina, Coll Pharm, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Emergency Med, Charleston, SC 29425 USA
关键词
atrial fibrillation; emergency medicine; procainamide; rhythm; RHYTHM-CONTROL; PHARMACOLOGICAL CARDIOVERSION; INTRAVENOUS MAGNESIUM; FLUTTER; CONVERSION; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; EFFICACY; OUTCOMES;
D O I
10.1097/TME.0000000000000306
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Atrial fibrillation (AF) is the most common tachyarrhythmia managed in the emergency department (ED). Visits to the ED for a presentation of AF have been increasing in recent years, with an admission rate that exceeds 60% in the United States and contributes substantially to health care costs. Recent-onset AF-defined as symptom onset less than 48 hr-is a common ED presentation for which rate control or acute electrical or pharmacological cardioversion may be appropriate treatment modalities depending on patient-specific circumstances. The focus of this review is to discuss the current recommendations regarding the management of recent-onset nonvalvular AF in the ED, discuss medication administration considerations, and identify implementation strategies in the ED to optimize throughput and reduce hospital admissions.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 50 条
  • [31] Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion
    Domanovits, H
    Schillinger, M
    Thoennissen, J
    Nikfardjam, M
    Janata, K
    Brunner, M
    Laggner, AN
    RESUSCITATION, 2000, 45 (03) : 181 - 187
  • [32] Management of acute atrial fibrillation in the emergency department: a recent experience
    Jacob, Javier
    Gomez, Joan
    Palom, Xavier
    Cabello, Irene
    Bardes, Ignasi
    EUROPEAN JOURNAL OF EMERGENCY MEDICINE, 2013, 20 (03) : 222 - 222
  • [33] Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department: A Systematic Review and Network Meta-analysis
    deSouza, Ian S.
    Tadrous, Mina
    Sexton, Theresa
    Benabbas, Roshanak
    Carmelli, Guy
    Sinert, Richard
    ANNALS OF EMERGENCY MEDICINE, 2020, 76 (01) : 14 - 30
  • [34] Intravenous Vernakalant A Review of its Use in the Management of Recent-Onset Atrial Fibrillation
    Duggan, Sean T.
    Scott, Lesley J.
    DRUGS, 2011, 71 (02) : 237 - 252
  • [35] Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation
    Boriani, Giuseppe
    Biffi, Mauro
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04): : 385 - 386
  • [36] Thyrotropin testing in recent-onset atrial fibrillation - Reply
    Krahn, A
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (12) : 1390 - 1390
  • [37] Spotlight on Intravenous Vernakalant in Recent-Onset Atrial Fibrillation
    Duggan, Sean T.
    Scott, Lesley J.
    DRUGS & AGING, 2011, 28 (06) : 501 - 504
  • [39] Intravenous VernakalantA Review of its Use in the Management of Recent-Onset Atrial Fibrillation
    Sean T. Duggan
    Lesley J. Scott
    Drugs, 2011, 71 : 237 - 252
  • [40] Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation
    Pluymaekers, Nikki A. H. A.
    Dudink, Elton A. M. P.
    Luermans, Justin G. L. M.
    Meeder, Joan G.
    Lenderink, Timo
    Widdershoven, Jos
    Bucx, Jeroen J. J.
    Rienstra, Michiel
    Kamp, Otto
    Van Opstal, Jurren M.
    Alings, Marco
    Oomen, Anton
    Kirchhof, Charles J.
    Van Dijk, Vincent F.
    Ramanna, Hemanth
    Liem, Anho
    Dekker, Lukas R.
    Essers, Brigitte A. B.
    Tijssen, Jan G. P.
    Van Gelder, Isabelle C.
    Crijns, Harry J. G. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (16): : 1499 - 1508